Amphastar Pharmaceuticals, Inc. (AMPH) Stock Profile — Insider Trades & Financials

Revenue$170.5M

Net Income$25.3M

EPS$0.51

Gross Margin50.0%

Market Cap$886.7M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Mary Z. Luo

CEO & Executive Director

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.

Employees: 1,615
Headquarters: RANCHO CUCAMONGA, CA, United States
Website: www.amphastar.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

3.37%

ROA?

1.55%

D/E Ratio?

1.16

Op. Margin?

21.87%

📊

Profitability Ratios

Net Margin?

14.83%

Loading company sections...

Amphastar Pharmaceuticals, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades

The morning brief, before the bell.

Amphastar Pharmaceuticals, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness

Recent Insider Trades